- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Astellas Pharma Inc
Total 2394 results
-
Astellas Pharma Global Development, Inc.CompletedHealthy VolunteersUnited States
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
Astellas Pharma Global Development, Inc.CompletedNon-Small-Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor MutationsUnited States
-
Astellas Pharma Global Development, Inc.CompletedCLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction | CLDN18.2-positive Adenocarcinoma of Esophagus | CLDN18.2-positive Gastric AdenocarcinomaGermany, Latvia
-
Astellas Pharma Global Development, Inc.WithdrawnHealthy Volunteers
-
Astellas Pharma Global Development, Inc.CompletedRheumatoid Arthritis (RA)United States, Poland
-
Astellas Pharma Global Development, Inc.CompletedLymphoma | Advanced Cancer | Refractory Solid TumorsUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedRheumatoid ArthritisMoldova, Republic of
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid Tumors | Pharmacokinetics of 14C-OSI-906United States
-
Astellas Pharma IncAstellas Pharma Global Development, Inc.CompletedSolid TumorsUnited States, Japan, Korea, Republic of, Taiwan
-
Astellas Pharma Global Development, Inc.No longer availableAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsAustralia, Italy, United Kingdom
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor (EGFR) MutationsUnited States
-
Astellas Pharma Global Development, Inc.CompletedHealthy Volunteers | Pharmacokinetics of ASP1941United States
-
Astellas Pharma China, Inc.Seagen Inc.Active, not recruitingMetastatic Urothelial CancerChina
-
Astellas Pharma IncActive, not recruitingPrimary Mitochondrial MyopathyUnited States
-
Astellas Pharma IncCompletedGastric Cancer | Gastro-esophageal Junction (GEJ) CancerJapan
-
Astellas Pharma IncTerminatedDuchenne Muscular Dystrophy (DMD)United States
-
Astellas Pharma IncCompletedLocally Advanced (Unresectable) or Metastatic Solid Tumor MalignanciesJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedAdvanced Solid TumorsJapan
-
Astellas Pharma IncCompletedArthritis, RheumatoidJapan, Korea, Republic of, Taiwan
-
Astellas Pharma IncCompletedInterstitial Pneumonia Associated With Polymyositis/DermatomyositisJapan
-
Astellas Pharma IncCompletedIrritable Bowel Syndrome With Constipation (IBS-C)Japan
-
Astellas Pharma IncCompletedOvarian Cancer | Solid TumorsUnited States, United Kingdom, Australia, Canada, Switzerland, Czechia, Italy, Poland, Romania, Russian Federation
-
Astellas Pharma IncCompletedAdvanced Solid TumorsUnited States, United Kingdom
-
Astellas Pharma IncCompletedRheumatoid Arthritis (RA)Japan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusUnited States, Hungary, Poland, Romania, Italy, United Kingdom
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedthe Maintenance Phase After Kidney TransplantationJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedPatients With Impaired Renal FunctionJapan
-
Astellas Pharma IncCompletedLiver Transplantation | MycosesBelgium, France, Italy, Spain, Ireland, Germany, Portugal, Saudi Arabia, Austria, United Kingdom, Russian Federation, Hungary, Sweden, Romania
-
Astellas Pharma IncCompletedKidney TransplantationTaiwan, Korea, Republic of
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedRestless Legs Syndrome (RLS)Japan
-
Astellas Pharma IncCompletedNSCLC | Non Small Cell Lung CancerUnited States, Canada, Korea, Republic of, Singapore, Thailand, Hong Kong
-
Astellas Pharma IncCompletedAllogeneic Hematopoietic Cell TransplantJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedPatients on Stable Chronic Maintenance Dialysis Who Are Receiving Hemodialysis Therapy | Pharmacodynamics of ASP7991 | Pharmacokinetics of ASP7991Japan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncTerminatedEGFR-TKI-naïve Patients With NSCLC Harboring EGFR Activating MutationsJapan
-
Astellas Pharma IncCompletedAdrenocortical CarcinomaUnited States, France, Netherlands, Italy, Canada, Germany, Australia, Poland, United Kingdom
-
Astellas Pharma IncCompletedKidney TransplantationAustralia, Austria, Belarus, Belgium, Czechia, France, Germany, Hong Kong, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Taiwan, Turkey
-
Astellas Pharma IncCompletedNeuralgia, PostherpeticFrance, Italy, Spain, Austria, Ireland, Belgium, United Kingdom, Romania, Slovenia, Greece, Czechia, Finland, Poland, Netherlands, Hungary, Slovakia
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedCandidiasisUnited Kingdom, Austria, France, Germany, Italy, Poland, Spain, Sweden